161 related articles for article (PubMed ID: 32477604)
1. Lipophilic Prodrug of Methotrexate in the Membrane of Liposomes Promotes Their Uptake by Human Blood Phagocytes.
Tretiakova DS; Khaidukov SV; Babayants AA; Frolova IS; Shcheglovitova ON; Onishchenko NR; Vodovozova EL
Acta Naturae; 2020; 12(1):99-109. PubMed ID: 32477604
[TBL] [Abstract][Full Text] [Related]
2. Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma.
Alekseeva AA; Moiseeva EV; Onishchenko NR; Boldyrev IA; Singin AS; Budko AP; Shprakh ZS; Molotkovsky JG; Vodovozova EL
Int J Nanomedicine; 2017; 12():3735-3749. PubMed ID: 28553111
[TBL] [Abstract][Full Text] [Related]
3. Hemocompatibility of liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the lipid bilayer.
Kuznetsova NR; Sevrin C; Lespineux D; Bovin NV; Vodovozova EL; Mészáros T; Szebeni J; Grandfils C
J Control Release; 2012 Jun; 160(2):394-400. PubMed ID: 22210161
[TBL] [Abstract][Full Text] [Related]
4. Influence of stabilizing components on the integrity of antitumor liposomes loaded with lipophilic prodrug in the bilayer.
Tretiakova D; Onishchenko N; Boldyrev I; Mikhalyov I; Tuzikov A; Bovin N; Evtushenko E; Vodovozova E
Colloids Surf B Biointerfaces; 2018 Jun; 166():45-53. PubMed ID: 29533843
[TBL] [Abstract][Full Text] [Related]
5. Differential binding of plasma proteins by liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the bilayer.
Kuznetsova NR; Vodovozova EL
Biochemistry (Mosc); 2014 Aug; 79(8):797-804. PubMed ID: 25365489
[TBL] [Abstract][Full Text] [Related]
6. [The influence of carbohydrate ligands on the cytotoxicity of liposomes bearing a methotrexate-diglyceride conjugate in human acute leukemia cell cultures].
Kuznetsova NR; Gaenko GP; Khaĭdukov SV; Bovin NV; Vodovozova EL
Bioorg Khim; 2009; 35(4):542-9. PubMed ID: 19928057
[TBL] [Abstract][Full Text] [Related]
7. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
Kim CK; Han JH
J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
[TBL] [Abstract][Full Text] [Related]
8. [Liposomal formulation of a methotrexate diglyceride conjugate: activity in methotrexate-resistant leukemia cultured cells].
Vodovozova EL; Kuznetsova NR; Gaenko GP; Molotkovskiĭ IuG
Bioorg Khim; 2007; 33(4):470-3. PubMed ID: 17886439
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol Stabilizes Fluid-Phase Liposomes Loaded with a Melphalan Lipophilic Prodrug.
Tretiakova D; Le-Deigen I; Onishchenko N; Kuntsche J; Kudryashova E; Vodovozova E
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33915726
[TBL] [Abstract][Full Text] [Related]
10. Effect of gangliosides on activation of the alternative pathway of human complement.
Michalek MT; Bremer EG; Mold C
J Immunol; 1988 Mar; 140(5):1581-7. PubMed ID: 3346542
[TBL] [Abstract][Full Text] [Related]
11. The effect of liposomally conjugated methotrexate upon mediator release from human peripheral blood monocytes.
Williams AS; Punn YL; Amos N; Cooper AM; Williams BD
Br J Rheumatol; 1995 Mar; 34(3):241-5. PubMed ID: 7728399
[TBL] [Abstract][Full Text] [Related]
12. Interactions of antitumour Sialyl Lewis X liposomes with vascular endothelial cells.
Alekseeva A; Kapkaeva M; Shcheglovitova O; Boldyrev I; Pazynina G; Bovin N; Vodovozova E
Biochim Biophys Acta; 2015 May; 1848(5):1099-110. PubMed ID: 25646577
[TBL] [Abstract][Full Text] [Related]
13. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
[TBL] [Abstract][Full Text] [Related]
14. Prolonged blood circulation of methotrexate by modulation of liposomal composition.
Hong MS; Lim SJ; Lee MK; Kim YB; Kim CK
Drug Deliv; 2001; 8(4):231-7. PubMed ID: 11757781
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cell proliferation with antibody-targeted liposomes containing methotrexate-gamma-dimyristoylphosphatidylethanolamine.
Noé C; Hernandez-Borrell J; Kinsky SC; Matsuura E; Leserman L
Biochim Biophys Acta; 1988 Dec; 946(2):253-60. PubMed ID: 3207742
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Liposomal Formulations on the Release and Brain Delivery of Methotrexate: An In Vivo Microdialysis Study.
Hu Y; Rip J; Gaillard PJ; de Lange ECM; Hammarlund-Udenaes M
J Pharm Sci; 2017 Sep; 106(9):2606-2613. PubMed ID: 28322936
[TBL] [Abstract][Full Text] [Related]
17. Liposomes containing alkylated methotrexate analogues for phospholipase A(2) mediated tumor targeted drug delivery.
Kaasgaard T; Andresen TL; Jensen SS; Holte RO; Jensen LT; Jørgensen K
Chem Phys Lipids; 2009 Feb; 157(2):94-103. PubMed ID: 19094974
[TBL] [Abstract][Full Text] [Related]
18. The effect of entrapment in liposomes on the in vivo distribution of [3H]methotrexate in a primate.
Kimelberg HK; Tracy TF; Biddlecome SM; Bourke RS
Cancer Res; 1976 Aug; 36(8):2949-57. PubMed ID: 819137
[TBL] [Abstract][Full Text] [Related]
19. Targeted brain delivery of methotrexate by glutathione PEGylated liposomes: How can the formulation make a difference?
Hu Y; Gaillard PJ; de Lange ECM; Hammarlund-Udenaes M
Eur J Pharm Biopharm; 2019 Jun; 139():197-204. PubMed ID: 30951819
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of internalized RGD-modified echogenic liposomes in diagnosis and treatment in a mouse model of rheumatoid arthritis].
Gan Z; Wu H; Wu HH; Zhou MJ; Yan F; Liu HM
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Oct; 37(10):1283-1289. PubMed ID: 29070455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
